Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

BACKGROUND: Varenicline is an efficacious smoking‐cessation drug. However, previous meta‐analyses provide conflicting results regarding its cardiovascular safety. The publication of several new randomized controlled trials (RCTs) provides an opportunity to reassess this potential adverse drug reacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterling, Lee H., Windle, Sarah B., Filion, Kristian B., Touma, Lahoud, Eisenberg, Mark J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802486/
https://www.ncbi.nlm.nih.gov/pubmed/26903004
http://dx.doi.org/10.1161/JAHA.115.002849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802486/
https://www.ncbi.nlm.nih.gov/pubmed/26903004
http://dx.doi.org/10.1161/JAHA.115.002849

Ejemplares similares